ACS Journal Cancer posted the following on X:
“Targeted therapy plays an important role for patients with early and advanced-stage NSCLC carrying specific genetic alterations. Hear from Dr. Maisam Makarem and Dr. Pasi Jänne of Dana-Farber Cancer Institute about the latest advances.”
Top Advances of the Year: Targeted Therapy for Lung Cancer
Authors: Maisam makarem, Pasi A. Jänne
